Artwork

Content provided by Children’s Mercy Kansas City. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Children’s Mercy Kansas City or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Identifying Novel Drug Treatment Options for Pediatric Osteosarcoma

 
Share
 

Manage episode 224411415 series 1067973
Content provided by Children’s Mercy Kansas City. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Children’s Mercy Kansas City or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
identifying-novel-drug-treatment-options-for-pediatric-osteosarcomaOsteosarcoma is highly metastatic and drug-resistant cancer. The survival rate for metastatic osteosarcoma remains less than 20 percent for the last 40 years. Tomoo Iwakuma, MD, PhD, is leading research focused on the elucidation of mechanisms underlying osteosarcoma progression and the discovery of novel drugs against this osteosarcoma. His laboratory has identified a lead compound that specifically killed canine and human osteosarcoma cells lacking the activity of the tumor suppressor p53, with minimal impact on non-tumor cells. Join us as we visit with Dr. Iwakuma about this promising research.
  continue reading

172 episodes

Artwork
iconShare
 
Manage episode 224411415 series 1067973
Content provided by Children’s Mercy Kansas City. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Children’s Mercy Kansas City or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
identifying-novel-drug-treatment-options-for-pediatric-osteosarcomaOsteosarcoma is highly metastatic and drug-resistant cancer. The survival rate for metastatic osteosarcoma remains less than 20 percent for the last 40 years. Tomoo Iwakuma, MD, PhD, is leading research focused on the elucidation of mechanisms underlying osteosarcoma progression and the discovery of novel drugs against this osteosarcoma. His laboratory has identified a lead compound that specifically killed canine and human osteosarcoma cells lacking the activity of the tumor suppressor p53, with minimal impact on non-tumor cells. Join us as we visit with Dr. Iwakuma about this promising research.
  continue reading

172 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide